Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 1,300 shares at $604.64 ($786K) on 2026-03-30, disclosed to the SEC on 2026-03-31.
Scheduled sale ($786k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |
| UTHR | SELL | 2025-09-25 | $440K | — | Filing → |